Healthy volunteers test three versions of experimental drug LY4065967

NCT ID NCT07607483

Recruiting now Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This early-phase study tests three different forms of the experimental drug LY4065967—a tablet and two types of capsules—in 36 healthy adults. The goal is to measure how much and how fast each form gets into the bloodstream and to check for side effects. Participants will stay at a research unit for three separate 3-night stays over about 7 weeks. This study does not aim to treat any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LY4065967

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

Fortrea Clinical Research Unit
RECRUITING

Daytona Beach, Florida, 32117, United States
Fortrea Clinical Research Unit
ACTIVE_NOT_RECRUITING

Dallas, Texas, 75247, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.